Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Esperion Therapeutics, Inc.
About ESPR
Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and delivering cardiometabolic and rare/orphan disease therapies. It markets two oral, once-daily, non-statin therapies for patients struggling to maintain their low-density lipoprotein cholesterol (LDL-C) levels who are at risk of cardiovascular disease and nasal spray, loop diuretic for the treatment of edema associated with congestive heart failure, and hepatic and renal disease. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. NEXLETOL is a first-in-class ACLY inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating LDL receptors. NEXLIZET contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and cholesterol absorption in the intestine. Its Enbumyst is the FDA-approved nasal spray loop diuretic.
Find out what a historical investment in Esperion Therapeutics, Inc. would be worth today using our ESPR stock calculator.
Market Capitalisation
$810.91M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
7.21M
High today
$3.15
Low today
$3.14
Open price
$3.14
52-week high
$4.18
52-week low
$0.95
Ready to start your investing journey with Stake?
Open an accountHow do I buy ESPR shares in Australia?
Buying ESPR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Esperion Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ESPR
What is the ticker symbol of Esperion Therapeutics, Inc.?
The ticker symbol for Esperion Therapeutics, Inc. is ESPR.
How much is one share of ESPR?
One share of ESPR is valued at $3.14 as of 10 June 2026.
What is the market capitalisation of Esperion Therapeutics, Inc. ESPR?
As of 10 June 2026 Esperion Therapeutics, Inc. has a market cap of $810.91M.
What is the 52-week high for Esperion Therapeutics, Inc. stock?
The Esperion Therapeutics, Inc. 52-week high stock price is $4.18.
What is the 52-week low for Esperion Therapeutics, Inc. stock?
The Esperion Therapeutics, Inc. 52-week low stock price is $0.95.
Can I buy ESPR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ESPR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ESPR on Stake
- Buy ESPR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ESPR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ESPR related stocks